David Cicurel, CEO, Brad Ormsby, CFO, Mark Lavelle, COO and Tim prestige, Group Business Development Director present Half Year results for the six months ended 30th June 2023, followed by Q&A. Solid organic and acquisition growth and a 23% increase to interim dividend.
David Cicurel, CEO
00:16 - Introduction
00:38 - About Judges Scientific
05:10 - Aqcuisition criteria
06:52 - The Judges Group
07:56 - HY23 Highlights
Brad Ormsby, CFO
10:42 - HY23 Financial Highlights
14:30 - Group performance
15:45 - Order intake
17:31 - Profit Bridge
18:26 - Balance Sheet & Cashflow
21:19 - Diversification
21:53- Financial history
David Cicurel, CEO
22:47 - Growth Drivers
23:20 - Henniker acquisition
24:06 - Bossa Nova Vision acquisition
Mark Lavelle, COO
25:46 - Post aquisition strategy
Tim Prestige, GBDD
31:13 - Post aquisition strategy continued
David Cicurel, CEO
38:19 - Outlook
39:40 - Investement case
40:52 - Q&A
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 22 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.
